Bafiertam is a medication that has been approved by the FDA for the treatment of relapsing forms of multiple sclerosis (MS). It is a novel formulation of monomethyl fumarate, which is a prodrug of dimethyl fumarate. This medication works by reducing inflammation in the central nervous system, which can help to decrease the frequency of MS relapses and slow down the progression of the disease.

Bafiertam is available in capsule form and is typically taken twice daily with food. It is important to follow the dosing instructions provided by your healthcare provider to ensure that you are receiving the full benefits of this medication. Some common side effects of Bafiertam may include flushing, stomach upset, and diarrhea. These side effects are usually mild and tend to improve over time as your body adjusts to the medication.

As with any medication, it is important to discuss with your healthcare provider any potential drug interactions or contraindications before starting Bafiertam. It is also important to inform your healthcare provider of any other medications or supplements you are currently taking to avoid any potential interactions.

Overall, Bafiertam is a promising treatment option for individuals with relapsing forms of MS. It has been shown to be effective in reducing the frequency of relapses and slowing down the progression of the disease. If you have been diagnosed with MS and are considering starting Bafiertam, be sure to discuss this option with your healthcare provider to determine if it is the right choice for you.